Mary J Johansen (Mary Johansen)

Years Active: 2020-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Filip Janku, Milind M Javle, Shiraj Sen, Shubham Pant, Lindsay G Bramwell, Vivek Subbiah, Tracey Way, David S Wages, Catherine A Wheeler, Takeaki Suzuki, Kazunori Saeki, Ruth Ann Subach, Timothy Madden, Gary Maier, Mary J Johansen, Kin Cheung, Gerald S Falchook
A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF-10502-01 for the treatment of advanced solid tumors. Cancer (2023)
Vivek Subbiah, William Erwin, Osama Mawlawi, Asa McCoy, David Wages, Catherine Wheeler, Carlos Gonzalez-Lepera, Holly Liu, Homer Macapinlac, Funda Meric-Bernstam, David S Hong, Shubham Pant, Dao Le, Elmer Santos, Jose Gonzalez, Jason Roszik, Takeaki Suzuki, Ruth Ann Subach, Timothy Madden, Mary J Johansen, Fumiko Nomura, Hirokazu Satoh, Tadashi Matsuura, Masamichi Kajita, Eri Nakamura, Yuichi Funase, Satoshi Matsushima, Gregory Ravizzini
Phase I Study of P-cadherin-targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (22) (2020)

Mary J Johansen.css-eqlu8i{font-size:small;padding-left:4px;} (Mary Johansen)